Tiziana Life Sciences (TLSA) Receives Grant by the Brigham and Women s Hospital to Explore anti-CD3 mAb streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
NEW YORK, Sept. 09, 2022 (GLOBE NEWSWIRE) Tiziana Life Sciences Ltd.(Nasdaq: TLSA) ("Tiziana" or the "Company"), a biotechnology company enabling breakthrough immunotherapies via novel routes of drug
Tiziana Life Sciences Ltd.(Nasdaq: TLSA) (“Tiziana” or the “Company”), a biotechnology company enabling breakthrough immunotherapies via novel routes of drug delivery, today announces that it has been notified that Matthew Davis, its Chief Medical Officer, purchased 100,000 common shares at $0.76 per share .
NEW YORK, Aug. 17, 2022 (GLOBE NEWSWIRE) Tiziana Life Sciences Ltd.(Nasdaq: TLSA) ("Tiziana" or the "Company"), a biotechnology company enabling breakthrough immunotherapies via novel routes of drug
Tiziana Life Sciences Announces Purchase of Common Shares by Executive Chairman streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.